Adjuvants and the promotion of Th1-type cytokines in tumour immunotherapy Keith DredgeBlake J. MarriottAngus G. Dalgleish Review Pages: 521 - 531
Therapeutic efficacy of melanoma-reactive TIL injected in stage III melanoma patients Nathalie LabarrièreMarie-Christine PandolfinoFrancine Jotereau Original Article Pages: 532 - 538
Randomized trial of adoptive transfer of melanoma tumor-infiltrating lymphocytes as adjuvant therapy for stage III melanoma Brigitte DrénoJean-Michel NguyenFrancine Jotereau Original Article Pages: 539 - 546
Rapid blood clearance of injected mouse IgG2a in SCID mice Rosana B. MichelRita OchakovskayaJules M. Mattes Original Article Pages: 547 - 556
Orally administered β-glucans enhance anti-tumor effects of monoclonal antibodies Nai-Kong V. CheungShakeel ModakBenny Knuckles Original Article Pages: 557 - 564
A functional recombinant single-chain T cell receptor fragment capable of selectively targeting antigen-presenting cells Malka EpelJoshua D. EllenhornYoram Reiter Original Article Pages: 565 - 573
Characterisation of tumour-associated antigens in colon cancer Aija LineZane SluckaRobert C. Rees Original Article Pages: 574 - 582